Introducing an alternative oxidant for Spiro-OMeTAD with the reduction product to passivate perovskite defects

Spiro-OMeTAD has been playing an indispensable role in highly efficient perovskite solar cells (PSCs). However, a long air oxidation process is usually required, which is harmful to the device stability. Herein, a simple and efficient doping strategy is proposed by adding a low-cost organic oxidant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of materials chemistry. C, Materials for optical and electronic devices Materials for optical and electronic devices, 2023-08, Vol.11 (33), p.11218-11224
Hauptverfasser: Gao, Xing, Wu, Fei, Zeng, Ye, Chen, Kaixing, Liu, Xiaorui, Zhu, Linna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Spiro-OMeTAD has been playing an indispensable role in highly efficient perovskite solar cells (PSCs). However, a long air oxidation process is usually required, which is harmful to the device stability. Herein, a simple and efficient doping strategy is proposed by adding a low-cost organic oxidant (2-iodoxybenzoic acid, IBX) to spiro-OMeTAD. IBX can accelerate the oxidation process of spiro-OMeTAD, thus effectively improving the conductivity and hole mobility of hole transport layers. What's more interesting, it is found that the reduction product of IBX, 2-iodobenzoic acid, can passivate the I vacancies and uncoordinated Pb 2+ defects on the surface of perovskite, thereby inhibiting nonradiative recombination. Ultimately, the IBX-treated PSCs achieved a power conversion efficiency of 22.45%, superior to that of the pristine device (20.42%). In addition, the stability of the IBX-based device is improved. Overall, the cost-effective, facile and dual functional doping strategy is quite promising in improving the efficiency and stability of PSCs. A low-cost organic oxidant IBX is used to oxidize spiro-OMeTAD. Moreover, the reduction product of IBX can passivate defects, and inhibit nonradiative recombination. The IBX-treated PSCs achieved a high efficiency of 22.45% with improved stability.
ISSN:2050-7526
2050-7534
DOI:10.1039/d3tc01601c